BOMBAY BURMAH TRADING CORPORATION
Back to All Ratios
|
BOMBAY BURMAH TRADING CORPORATION Last 5 Year Price to Cash Earnings (PCE) History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| PCE(x) | 4.88 | 5.45 | -10.64 | 5.92 | 5.20 |
What is the latest Price to Cash Earnings (PCE) ratio of BOMBAY BURMAH TRADING CORPORATION ?
| Year | Price to Cash Earnings (PCE) |
|---|---|
| Mar2025 | 4.88 |
| Mar2024 | 5.45 |
| Mar2023 | -10.64 |
| Mar2022 | 5.92 |
| Mar2021 | 5.20 |
How is Price to Cash Earnings (PCE) of BOMBAY BURMAH TRADING CORPORATION Trending?
| Years | Price to Cash Earnings (PCE) | % Change | |
|---|---|---|---|
| Mar2025 | 4.88 | -10.46 | |
| Mar2024 | 5.45 | Positive | |
| Mar2023 | -10.64 | Negative | |
| Mar2022 | 5.92 | 13.85 | |
| Mar2021 | 5.2 | - | |
Other Financial Ratios of BOMBAY BURMAH TRADING CORPORATION
| Operational & Financial Ratios Earnings Per Share CEPS DPS Book NAV/Share Tax Rate | Margin Ratios Core EBITDA Margin EBIT Margin Pre Tax Margin PAT Margin Cash Profit Margin | Performance Ratios ROA ROE ROCE Asset Turnover Sales/Fixed Asset Working Capital/Sales | Efficiency Ratios Fixed Capital/Sales Receivable days Inventory Days Payable days | Valuation Parameters PER Price/Book Yield EV/Net Sales EV/Core EBITDA EV/EBIT EV/CE M Cap / Sales | Growth Ratios Net Sales Growth Core EBITDA Growth EBIT Growth PAT Growth EPS Growth | Financial Stability Ratios Total Debt/Equity Current Ratio Quick Ratio Interest Cover Total Debt/Mcap |
Compare Price to Cash Earnings (PCE) ratio of peers of BOMBAY BURMAH TRADING CORPORATION
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| BOMBAY BURMAH TRADING CORPORATION | ₹13,087.5 Cr | -1.4% | -0.9% | -31.9% | Stock Analytics | |
| KAVERI SEED COMPANY | ₹5,496.3 Cr | 6.2% | 0.6% | 7.7% | Stock Analytics | |
| VENKYS (INDIA) | ₹1,901.0 Cr | -3.1% | -8.9% | -23.1% | Stock Analytics | |
| BOMBAY SUPER HYBRID SEEDS | ₹1,230.4 Cr | -1.7% | -5.4% | -28.1% | Stock Analytics | |
| MANGALAM GLOBAL ENTERPRISE | ₹462.0 Cr | 1.5% | -16.3% | 13.3% | Stock Analytics | |
| INDO US BIOTECH | ₹260.9 Cr | -2.5% | -0.5% | -46.4% | Stock Analytics | |
BOMBAY BURMAH TRADING CORPORATION Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| BOMBAY BURMAH TRADING CORPORATION | -1.4% |
-0.9% |
-31.9% |
| SENSEX | 1.4% |
2.4% |
5.1% |
You may also like the below Video Courses